Article Details
Retrieved on: 2022-05-06 02:25:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vir Biotechnology, Inc. – $1.2 billion of sotrovimab collaboration revenue recognized in the first quarter –. – More than $2.5 billion in cash, cash ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here